ACTH 1-39 Peptide Supplier China: COA Buyer Guide

Specify sequence, species and termini

Write ACTH 1-39 with the complete amino-acid sequence or authoritative molecular reference, species source or sequence identity, termini, modifications where applicable, material form, target purity, 5mg nominal content and RUO status. Map Seractide or other aliases only after confirming the exact construct. Require consistency across quotation, specification, COA, analytical sample, vial label and packing list. ACTH fragments, different species sequences or products labeled only ACTH are not automatically equivalent.

Check the full 1-39 identity, not a fragment

The numbering is part of the product identity. Ask the supplier to confirm that the analytical target is the full specified 1-39 sequence rather than a shorter active fragment or related melanocortin peptide. Review expected molecular information, sequence documentation and product code. A marketing description of the biological region does not prove what was synthesized. Resolve any mismatch among name, CAS, sequence, mass and report identifiers before commercial approval and prohibit unreviewed substitutions.

Review lot-specific HPLC and MS evidence

Require complete chromatographic-purity and molecular-identity files for the offered batch. Check sample ID, expected and observed molecular information, chromatogram, integration, method reference, test date, report number and authorization. Ask how the sample connects to bulk material and filled 5mg units. A high HPLC percentage cannot by itself demonstrate the full sequence, species assignment, exact vial content or every modification. Record method limits and investigate unexplained peaks, retests or revised files.

Verify the 5mg quantity basis

Ask which quantitative method or controlled filling record supports 5mg and what tolerance applies. Confirm whether the amount means net ACTH 1-39 peptide or total lyophilized mass. If excipients are present, obtain enough information to interpret the claim. Keep identity, chromatographic purity and quantitative content as separate acceptance criteria. Reconcile issued, filled, rejected and remaining quantities where applicable. Compare offers by total documented target material rather than only vials or kit price.

Control labels, storage and supplier accountability

Approve labels showing ACTH 1-39, strength, lot and RUO wording. Obtain supported storage and transport conditions, packaging and excursion procedures. Map seller, synthesis site, laboratory, filler, release authority, inventory owner and shipper. Confirm released stock, MOQ, document timing and change notification. On receipt, inspect labels, seals, lot and quantity and quarantine any sequence, species, strength, temperature or document discrepancy until a traceable investigation and quality decision are complete.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• ACTH 1-39 5mg
• Oxytocin Supplier Guide
• Gonadorelin vs Triptorelin Guide

Frequently asked questions